Symposium:
123. Big Beasts II
Friday, October 28, 2016: 10:30 AM-12:00 PM
Room: La Nouvelle Orleans Ballroom

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the impact of respiratory syncytial virus infection in older adults
  • define the factors leading the increase in invasive group B streptococcal disease in non-pregnant adults
  • cite data supporting the type and duration of antimicrobials for early Lyme disease

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Hospital epidemiologists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Researchers, Scientists

Tracks: Adult ID, Epidemiology and Infection Control, Pediatric ID

Moderators:  Samuel Shelburne, MD, PhD, FIDSA, The University of Texas MD Anderson Cancer Center and Carol J. Baker, MD, FIDSA, FSHEA, FPIDS, Texas Children’s Hospital, Baylor College of Medicine

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-260-L01-P

Disclosures:

S. Shelburne, None

C. J. Baker, Pfizer, Inc.: Consultant , Consulting fee
CureVac, Inc.: Consultant , Consulting fee
Seqirus, Inc.: Consultant , Consulting fee

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.